0001968202-24-000084.txt : 20240305
0001968202-24-000084.hdr.sgml : 20240305
20240305160149
ACCESSION NUMBER: 0001968202-24-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN ARTHUR F
CENTRAL INDEX KEY: 0001187443
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 24720167
MAIL ADDRESS:
STREET 1: CITIZENS FINANCIAL GROUP, INC
STREET 2: 600 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-01
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001187443
RYAN ARTHUR F
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
1
Common Stock
2024-03-01
4
S
0
1
967.5
D
18381
D
Common Stock
2024-03-01
4
S
0
1
968.66
D
18380
D
Common Stock
2024-03-01
4
S
0
1
969.18
D
18379
D
Common Stock
2024-03-01
4
S
0
4
970.38
D
18375
D
Common Stock
2024-03-01
4
S
0
1
971.75
D
18374
D
Common Stock
2024-03-01
4
S
0
2
972.29
D
18372
D
Common Stock
2024-03-01
4
S
0
1
974.78
D
18371
D
Common Stock
2024-03-01
4
S
0
2
975.7
D
18369
D
Common Stock
2024-03-01
4
S
0
2
976.81
D
18367
D
Common Stock
2024-03-01
4
S
0
2
977.27
D
18365
D
Common Stock
2024-03-01
4
S
0
1
978.09
D
18364
D
Common Stock
2024-03-01
4
S
0
1
979.87
D
18363
D
Common Stock
2024-03-01
4
S
0
1
980.21
D
18362
D
Common Stock
2024-03-01
4
S
0
15
981.64
D
18347
D
Common Stock
2024-03-01
4
S
0
11
982.67
D
18336
D
Common Stock
2024-03-01
4
S
0
12
983.61
D
18324
D
Common Stock
2024-03-01
4
S
0
19
984.45
D
18305
D
Common Stock
2024-03-01
4
S
0
10
985.76
D
18295
D
Common Stock
2024-03-01
4
S
0
8
986.58
D
18287
D
Common Stock
2024-03-01
4
S
0
4
987.33
D
18283
D
Common Stock
2024-03-01
4
S
0
1
988.3
D
18282
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2024 at prices ranging from $977.00 to $977.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 15 shares of Company stock on March 1, 2024 at prices ranging from $981.09 to $981.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 11 shares of Company stock on March 1, 2024 at prices ranging from $982.51 to $982.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 12 shares of Company stock on March 1, 2024 at prices ranging from $983.21 to $983.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 19 shares of Company stock on March 1, 2024 at prices ranging from $984.00 to $984.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2024 at prices ranging from $985.26 to $985.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2024 at prices ranging from $986.45 to $986.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2024 at prices ranging from $987.05 to $987.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
/s/**Arthur F. Ryan
2024-03-05